NEW YORK (
) has been upgraded by TheStreet Ratings from hold to buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
SonoSite, Inc. develops, manufactures, and distributes hand-carried ultrasound systems for use across medical specialties and in a range of treatment settings. The company has a P/E ratio of 87, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 23.4. SonoSite has a market cap of $469.2 million and is part of the
industry. Shares are up 10.1% year to date as of the close of trading on Thursday.
You can view the full
or get investment ideas from our